Endoscopic Ultrasound Market Summary

• The Endoscopic Ultrasound market is estimated at USD 640 million in 2025 and is projected to reach USD 1.28 billion by 2034. Growth is anchored in the rising burden of gastrointestinal and pancreaticobiliary cancers, the rapid expansion of endoscopic ultrasound-guided diagnostic and therapeutic procedures, and continued innovation in echoendoscopes, imaging processors, and fine-needle sampling devices.
• The global Endoscopic Ultrasound market is growing at a CAGR of 8.0% during the forecast period from 2026 to 2034.
• By product, the endoscopic ultrasound endoscopes segment dominated the Endoscopic Ultrasound market with a 54% share in 2025.
• By type, the linear endoscopic ultrasound segment dominated the Endoscopic Ultrasound market with a share of 62% in 2025.
• By application, the oncology segment dominated the Endoscopic Ultrasound market with a share of 46% in 2025.
• By end-user, the hospitals segment dominated the Endoscopic Ultrasound market with a share of 68% in 2025.
• North America dominated the global Endoscopic Ultrasound market revenue with a share of 38% in 2025, representing the highest regional market share globally.

Endoscopic ultrasound (EUS) is a minimally invasive diagnostic and therapeutic technology that combines endoscopy with high-frequency ultrasound imaging, using an ultrasound transducer mounted on the tip of an endoscope to visualize the gastrointestinal tract wall and adjacent organs from within the body. A complete endoscopic ultrasound system comprises echoendoscopes, available in radial and linear or curvilinear configurations and as through-the-scope miniature probes, dedicated ultrasound processors and imaging systems, and a range of needles and accessories, including fine-needle aspiration and fine-needle biopsy devices used for tissue sampling. Endoscopic ultrasound is central to the diagnosis and staging of gastrointestinal, pancreaticobiliary, and thoracic cancers, and to a growing array of interventional procedures such as EUS-guided fine-needle sampling, drainage, and stent placement, as well as endobronchial ultrasound for lung cancer staging. Over the past decade, the field has advanced from diagnostic radial imaging toward interventional linear EUS, high-resolution and contrast-enhanced imaging, therapeutic EUS with lumen-apposing metal stents, and artificial-intelligence-assisted interpretation, establishing endoscopic ultrasound as an essential technology across gastroenterology, oncology, and pulmonology worldwide.

Endoscopic Ultrasound Market Key Growth Drivers 

• The rising global burden of gastrointestinal and pancreaticobiliary cancers is a primary driver, with the International Agency for Research on Cancer reporting 20 million new cancer cases in 2022 and projecting 35 million by 2050.
• The rapid expansion of endoscopic ultrasound-guided interventional procedures, including fine-needle sampling, drainage, and stent placement, is broadening clinical use.
• The growing adoption of endobronchial ultrasound for minimally invasive lung cancer staging is expanding the application base.
• The preference for minimally invasive diagnosis and tissue sampling over surgical approaches is driving endoscopic ultrasound adoption.
• Technological advances, including high-resolution imaging, elastography, contrast-enhanced endoscopic ultrasound, and improved fine-needle biopsy devices, are improving diagnostic yield.
• The integration of artificial intelligence into endoscopic ultrasound image analysis is enhancing lesion characterization and diagnostic accuracy.
• The convergence of rising cancer burden, interventional procedure growth, and imaging and needle innovation is expected to sustain strong growth in the global Endoscopic Ultrasound market through 2034.

Key Companies in Endoscopic Ultrasound Market

The competitive landscape is led by the following active manufacturers and solution providers:

• Olympus Corporation
• Fujifilm Corporation
• Boston Scientific Corporation
• Pentax Medical (HOYA Corporation)
• Cook Medical LLC
• Medtronic plc
• ConMed Corporation
• SonoScape Medical Corp.
• Medi-Globe Group
• B. Braun SE

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies relevant to the market assessment.

Endoscopic Ultrasound Market Size

The following snapshot summarizes the principal report metrics for the Endoscopic Ultrasound market.

All market values are expressed in USD and represent DelveInsight estimates synthesized from primary and secondary research.

Factors Contributing to the Growth of the Endoscopic Ultrasound Market

Market Drivers

Rising Burden of Gastrointestinal and Pancreaticobiliary Cancers

The escalating burden of gastrointestinal and pancreaticobiliary cancers is the foundational driver of endoscopic ultrasound demand. According to the International Agency for Research on Cancer, approximately 20 million new cancer cases were diagnosed in 2022, with cases projected to reach 35 million by 2050, and gastrointestinal cancers, including pancreatic, esophageal, gastric, and biliary malignancies, represent a substantial and rising share. Endoscopic ultrasound is a cornerstone technology for the diagnosis, tissue sampling, and locoregional staging of these cancers, offering superior visualization of the gastrointestinal wall and adjacent structures compared with cross-sectional imaging. Pancreatic cancer in particular relies on endoscopic ultrasound with fine-needle sampling for diagnosis, given the limitations of other modalities. As the incidence of gastrointestinal and pancreaticobiliary cancers rises with aging populations and changing risk factors, and as earlier detection increases the number of diagnosable lesions, the volume of endoscopic ultrasound procedures grows. This expanding oncologic demand creates durable and growing use of endoscopic ultrasound systems and accessories, reinforcing sustained market growth throughout the forecast period.

Expansion of Interventional and Therapeutic Endoscopic Ultrasound

The rapid growth of interventional and therapeutic endoscopic ultrasound is a powerful catalyst for market expansion. Beyond diagnostic imaging, endoscopic ultrasound now guides a broad and expanding array of procedures, including fine-needle aspiration and biopsy for tissue diagnosis, drainage of pancreatic fluid collections, biliary and gallbladder access, gastroenterostomy, and celiac plexus interventions. The advent of lumen-apposing metal stents, such as Boston Scientific's AXIOS system, has enabled endoscopic ultrasound-guided drainage and anastomosis procedures that were previously surgical, dramatically broadening the therapeutic scope of the technology. Linear echoendoscopes, which enable real-time needle guidance, are central to these interventions. The shift of complex procedures from surgery to endoscopic ultrasound-guided approaches reduces morbidity and cost while expanding the clinical value and utilization of the technology. As therapeutic endoscopic ultrasound continues to mature and new procedures and devices emerge, interventional applications are expected to be a leading driver of market growth across the forecast period.

Growing Adoption of Endobronchial Ultrasound for Lung Cancer Staging

The expanding use of endobronchial ultrasound for minimally invasive lung cancer staging is broadening the endoscopic ultrasound application base. Endobronchial ultrasound with transbronchial needle aspiration has become the standard of care for mediastinal lymph node staging in lung cancer, offering a minimally invasive alternative to surgical mediastinoscopy with high diagnostic accuracy. As lung cancer remains one of the most common and deadly cancers worldwide, and as accurate mediastinal staging is critical to treatment planning, demand for endobronchial ultrasound systems and needles continues to grow. Manufacturers including Olympus, Fujifilm, and Pentax offer dedicated endobronchial ultrasound scopes and processors, and needle providers such as Cook Medical and Boston Scientific supply the associated sampling devices. The growing emphasis on molecular profiling of lung cancer further increases the need for adequate tissue acquisition through endobronchial ultrasound. As lung cancer screening and diagnosis expand, endobronchial ultrasound is expected to be an important contributor to endoscopic ultrasound market growth across the forecast period.

Preference for Minimally Invasive Diagnosis and Tissue Sampling

The strong clinical preference for minimally invasive diagnosis is driving endoscopic ultrasound adoption. Endoscopic ultrasound-guided fine-needle sampling provides accurate tissue diagnosis of gastrointestinal, pancreatic, and mediastinal lesions with lower morbidity, faster recovery, and greater patient acceptance than surgical biopsy. The ability to obtain high-quality tissue for histology and molecular analysis through a single minimally invasive procedure supports precision oncology and treatment planning. Advances in fine-needle biopsy devices, such as Boston Scientific's Acquire and Cook Medical's EchoTip needles, have improved tissue yield and diagnostic adequacy, reinforcing the role of endoscopic ultrasound in diagnosis. As healthcare systems and patients increasingly favor minimally invasive approaches and as the demand for tissue for molecular testing grows, endoscopic ultrasound-guided sampling is expected to expand. This preference for minimally invasive, high-yield diagnosis is a durable driver of endoscopic ultrasound utilization and accessory demand across the forecast period.

Technological Advancement in Imaging and Sampling

Continuous technological innovation is enhancing the diagnostic capability and value of endoscopic ultrasound. Advances in high-resolution ultrasound imaging, contrast-enhanced endoscopic ultrasound, and elastography improve the characterization of lesions and the differentiation of benign from malignant tissue, while improved processors such as Olympus's EU-ME series enhance image quality and integration. Innovations in fine-needle biopsy needle design have increased tissue yield and reduced the number of passes required, and needle-based confocal laser endomicroscopy adds in vivo microscopic assessment. The development of therapeutic devices, including lumen-apposing metal stents and dedicated delivery systems, has expanded interventional capability. These advances improve diagnostic accuracy, procedural efficiency, and the range of treatable conditions, and they differentiate competing systems. As imaging, needle, and therapeutic technologies continue to advance, ongoing innovation is expected to be a significant driver of endoscopic ultrasound adoption and premium positioning across the forecast period.

Integration of Artificial Intelligence and Digital Imaging

The integration of artificial intelligence into endoscopic ultrasound is enhancing diagnostic accuracy and workflow. Artificial-intelligence algorithms are increasingly applied to endoscopic ultrasound and broader gastrointestinal endoscopy to support lesion detection, characterization, and staging, reducing operator dependence and improving consistency in a field known for a steep learning curve. Machine learning models assist in differentiating pancreatic lesions, identifying subepithelial tumors, and standardizing image interpretation, while digital imaging and archiving support quality assurance and training. The combination of artificial intelligence with high-resolution imaging promises to make endoscopic ultrasound more accessible and reliable, addressing one of the key barriers to wider adoption. Vendors and digital health companies are investing in artificial-intelligence-enabled endoscopy platforms. As these tools mature and gain regulatory acceptance, artificial intelligence is expected to improve the diagnostic value and adoption of endoscopic ultrasound, contributing to market growth and competitive differentiation across the forecast period.

Market Restraints

Despite strong momentum, the Endoscopic Ultrasound market faces material constraints. The high cost of endoscopic ultrasound systems, including echoendoscopes and processors, and the ongoing expense of single-use needles and accessories place pressure on healthcare budgets and can limit adoption, particularly in smaller centers and cost-sensitive markets. Endoscopic ultrasound has a steep learning curve and requires highly trained endosonographers, and a shortage of skilled operators constrains adoption and limits the technology to specialized centers. The complexity of interventional procedures further raises training and credentialing requirements. Reprocessing and infection control are significant concerns, as reusable echoendoscopes are complex to clean and have been associated with transmission risks, driving regulatory scrutiny and adding operational burden. Reimbursement variability across geographies and procedures affects adoption, and the capital investment required for endoscopic ultrasound may be difficult to justify for lower-volume centers. Competition from cross-sectional imaging modalities such as computed tomography and magnetic resonance imaging, which are non-invasive and widely available, can substitute for endoscopic ultrasound in some staging applications. Regulatory requirements under frameworks such as the European Medical Device Regulation raise evidence and compliance burdens and lengthen time to market. Finally, uneven access to endoscopy infrastructure and trained specialists in emerging markets restrains the pace of adoption across parts of the sector.

Endoscopic Ultrasound Market Segment Analysis

The Endoscopic Ultrasound Market is segmented by product (endoscopic ultrasound endoscopes, endoscopic ultrasound processors and imaging systems, needles and accessories), type (radial endoscopic ultrasound, linear endoscopic ultrasound, endoscopic ultrasound miniprobes), application (oncology, gastroenterology and pancreaticobiliary, pulmonology, others), end-user (hospitals, ambulatory surgical centers and endoscopy centers, others), and geography (north america, europe, asia-pacific, rest of world).

By Product

Dominant Subsegment: Endoscopic Ultrasound Endoscopes. 

The endoscopic ultrasound endoscopes segment accounted for 54% of the Endoscopic Ultrasound market in 2025. Echoendoscopes, comprising radial and linear or curvilinear scopes, dominate because they are the core, high-value capital component of every endoscopic ultrasound system and are essential to both diagnostic and interventional procedures. The scopes integrate an ultrasound transducer with a flexible endoscope, representing sophisticated, premium-priced devices, and the installed base of echoendoscopes drives the utilization of processors and accessories. Olympus, Fujifilm, and Pentax Medical anchor this segment with comprehensive radial and linear echoendoscope portfolios and dedicated endobronchial ultrasound scopes. Endoscopic ultrasound processors and imaging systems, such as Olympus's EU-ME series, represent an important capital segment that provides the imaging platform, while needles and accessories, including fine-needle aspiration and biopsy devices from Boston Scientific, Cook Medical, and Medtronic, generate recurring, procedure-linked revenue that grows with interventional volumes. Nonetheless, the central role, capital intensity, and premium value of echoendoscopes secure the segment's leadership across the forecast period, while needles and accessories represent the fastest-growing recurring segment.

By Type

Dominant Subsegment: Linear Endoscopic Ultrasound. 

The linear endoscopic ultrasound segment accounted for 62% of the Endoscopic Ultrasound market in 2025. Linear or curvilinear endoscopic ultrasound dominates because it enables real-time visualization of a needle along the imaging plane, making it essential for fine-needle aspiration and biopsy and for the growing range of interventional and therapeutic procedures. As endoscopic ultrasound has shifted from purely diagnostic imaging toward tissue sampling and therapy, linear echoendoscopes have become the workhorse of the field, supporting drainage, stent placement, and other guided interventions. The expansion of therapeutic endoscopic ultrasound, including lumen-apposing metal stent procedures, further reinforces demand for linear scopes. Radial endoscopic ultrasound, which provides a 360-degree cross-sectional view, remains valuable for diagnostic imaging and locoregional staging and represents an important segment, while through-the-scope miniprobes serve specific applications such as the assessment of strictures and superficial lesions. Nonetheless, the interventional capability, clinical versatility, and central role in tissue sampling and therapy secure the leadership of linear endoscopic ultrasound across the forecast period, as diagnostic and therapeutic use continues to grow.

By Application

Dominant Subsegment: Oncology. 

The oncology segment accounted for 46% of the Endoscopic Ultrasound market in 2025. Oncology dominates because endoscopic ultrasound is a cornerstone technology for the diagnosis, tissue sampling, and locoregional staging of gastrointestinal, pancreaticobiliary, and thoracic cancers, which represent a large and rising share of the global cancer burden of 20 million new cases reported in 2022 by the International Agency for Research on Cancer. Endoscopic ultrasound with fine-needle sampling is central to the diagnosis of pancreatic cancer and to the staging of esophageal, gastric, and rectal cancers, and endobronchial ultrasound is standard for lung cancer mediastinal staging. The growing demand for tissue to support molecular profiling and precision oncology further increases oncologic use. Gastroenterology and pancreaticobiliary applications, including the evaluation of subepithelial lesions, pancreatic cysts, and biliary disease, and increasingly therapeutic drainage, represent a large and growing segment, while pulmonology through endobronchial ultrasound and other applications add further demand. Nonetheless, the central role of endoscopic ultrasound in cancer diagnosis and staging and the rising cancer burden secure the leadership of the oncology segment across the forecast period.

By End-User

Dominant Subsegment: Hospitals. 

The hospitals segment accounted for 68% of the Endoscopic Ultrasound market in 2025. Hospitals dominate because endoscopic ultrasound is a complex, specialized procedure that requires advanced equipment, trained endosonographers, and the multidisciplinary infrastructure for diagnosis, tissue processing, and increasingly therapeutic intervention that hospitals are uniquely equipped to provide. The concentration of cancer diagnosis and staging, complex pancreaticobiliary procedures, and therapeutic endoscopic ultrasound in hospital and academic medical center settings drives the majority of procedure volume, and hospitals are the primary purchasers of capital-intensive echoendoscopes and processors. Teaching and tertiary hospitals also lead the adoption of advanced imaging, therapeutic devices, and artificial-intelligence-enabled systems, and serve as training centers for the specialized skills endoscopic ultrasound requires. Ambulatory surgical centers and dedicated endoscopy centers represent a growing end user as diagnostic and routine procedures shift to outpatient settings, though the complexity and capital requirements of endoscopic ultrasound limit this migration relative to general endoscopy. Nonetheless, hospitals retain clear leadership in 2025 on the strength of their procedure volume, specialization, and infrastructure across the forecast period.

Endoscopic Ultrasound Market Region Analysis

Dominant Region: North America

North America accounted for 38% of the global Endoscopic Ultrasound market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high burden of gastrointestinal and pancreaticobiliary cancers, advanced endoscopy infrastructure, and early adoption of interventional and therapeutic endoscopic ultrasound. The United States leads on the strength of a large network of academic medical centers and endoscopy units, high procedure volumes in cancer diagnosis and staging, and rapid uptake of therapeutic endoscopic ultrasound, including lumen-apposing metal stent procedures. Disease burden is substantial, with a large aging population and rising incidence of pancreatic and other gastrointestinal cancers. The regulatory environment is well defined, with the Food and Drug Administration providing established pathways for echoendoscopes, processors, and needles, and issuing guidance on endoscope reprocessing. Reimbursement for endoscopic ultrasound procedures is comparatively favorable, and a concentration of leading manufacturers and highly trained endosonographers supports adoption. Strong clinical research and training infrastructure further reinforce demand. This combination of disease burden, infrastructure, and innovation reinforces North America's leadership in the global market.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Endoscopic Ultrasound market. The region's elevated CAGR is driven by large populations, a high and rising burden of gastrointestinal cancers, and rapidly expanding endoscopy and interventional capacity across China, Japan, India, South Korea, and Australia. The region has among the highest incidence of gastric, esophageal, and other gastrointestinal cancers in the world, driving strong demand for endoscopic ultrasound diagnosis and staging. Japan, a pioneer in endoscopy, has advanced adoption and manufacturing, and growing healthcare investment, expanding cancer screening, and rising numbers of trained endosonographers are accelerating adoption across the region. Both global manufacturers, including Olympus, Fujifilm, and Pentax, and regional providers such as SonoScape are expanding their presence with echoendoscopes, processors, and accessories. Government initiatives to strengthen cancer diagnosis and endoscopy capacity further support growth. The combination of large patient populations, high gastrointestinal cancer burden, and expanding endoscopy infrastructure positions Asia-Pacific as the highest-growth region over the forecast period.

Regional Commentary

North America

North America accounted for 38% of the global Endoscopic Ultrasound market revenue in 2025. The United States dominates the region on the strength of high procedure volumes, extensive interventional and therapeutic endoscopic ultrasound adoption, advanced endoscopy infrastructure, and the presence of leading manufacturers and trained endosonographers, while Canada advances through public healthcare adoption and Mexico expands endoscopy capacity within its growing healthcare sector.

Europe

Europe represents the second-largest regional market, led by Germany, France, and the United Kingdom. Growth is supported by a high burden of gastrointestinal cancers, established endoscopy and interventional endoscopic ultrasound adoption, and the presence of major manufacturers, while the European Medical Device Regulation shapes requirements for echoendoscopes and accessories.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by large populations, a high burden of gastrointestinal cancers, and expanding endoscopy capacity across China, Japan, India, South Korea, and Australia. Japan's endoscopy leadership and manufacturing, together with growing cancer screening and rising numbers of trained endosonographers, are broadening adoption.

Rest of World

The Rest of World region, spanning the Middle East, Africa, and South America, is an emerging growth frontier. A rising gastrointestinal cancer burden, gradual improvements in endoscopy infrastructure, and increasing availability of endoscopic ultrasound systems are expanding access, while investment in cancer diagnosis and endoscopy training supports the broader adoption of endoscopic ultrasound.

Endoscopic Ultrasound Market Competitive Landscape

The Endoscopic Ultrasound market is classified as Consolidated. A small group of endoscopy manufacturers controls the majority of echoendoscope and processor revenue, led by Olympus, Fujifilm, and Pentax Medical, while a broader field of device companies, including Boston Scientific, Cook Medical, Medtronic, ConMed, and Medi-Globe, competes in the needles and accessories segment, and regional manufacturers such as SonoScape expand their presence. The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Consolidated, with echoendoscope and processor revenue concentrated among a few endoscopy leaders and high barriers from imaging technology and installed base.
• Leading players: Olympus, Fujifilm, and Pentax Medical anchor scopes and processors, with Boston Scientific, Cook Medical, and Medtronic strong in needles and therapeutic devices.
• Geographic reach: Leaders operate global commercial, service, and training networks, with strong positions across North America, Europe, and Asia-Pacific.
• Product portfolio strength: Top players offer integrated portfolios spanning radial and linear echoendoscopes, processors, needles, and therapeutic devices.
• Pipeline strength: Active development in high-resolution and contrast-enhanced imaging, therapeutic endoscopic ultrasound, fine-needle biopsy, and artificial intelligence.
• Strategic partnerships: Collaborations among scope makers, needle and stent providers, and digital health companies extend capability across diagnostic and therapeutic workflows.
• M&A activity: Consolidation continues as companies acquire therapeutic endoluminal and accessory assets to broaden endoscopic ultrasound portfolios.
• Manufacturing capabilities: Precision manufacturing of echoendoscopes and ultrasound transducers is a key competitive moat and a barrier to entry.
• Innovation focus: Interventional and therapeutic endoscopic ultrasound, high-resolution imaging, improved fine-needle biopsy, single-use designs, and AI-assisted interpretation.

Endoscopic Ultrasound Market Recent Developmental Activities

In 2023 and 2024, Olympus Corporation advanced its endoscopic ultrasound portfolio, including radial and linear echoendoscopes and the EU-ME series ultrasound processors for endoscopic and endobronchial ultrasound. Strategic significance: Reinforces Olympus's leadership in echoendoscopes and processors across diagnostic and interventional endoscopic ultrasound.

In 2023 and 2024, Fujifilm Corporation advanced its endoscopic ultrasound systems and echoendoscopes, integrating high-resolution imaging with its endoscopy platform. Strategic significance: Strengthens Fujifilm's position as a leading echoendoscope and processor provider and intensifies competition with Olympus.

In 2023 and 2024, Boston Scientific Corporation advanced its AXIOS lumen-apposing metal stent system and acquired fine-needle biopsy devices for endoscopic ultrasound-guided procedures. Strategic significance: Expands therapeutic endoscopic ultrasound and tissue acquisition, driving interventional adoption and recurring accessory revenue.

In 2023, Boston Scientific Corporation completed its acquisition of Apollo Endosurgery, expanding its endoluminal and therapeutic endoscopy portfolio. Strategic significance: Broadens Boston Scientific's interventional endoscopy franchise adjacent to endoscopic ultrasound-guided therapy.

In 2023 and 2024, Cook Medical LLC advanced its EchoTip fine-needle aspiration and biopsy needles for endoscopic and endobronchial ultrasound. Strategic significance: Sustains Cook's position in endoscopic ultrasound tissue sampling and supports diagnostic procedure growth.

In 2023 and 2024, Pentax Medical advanced its endoscopic ultrasound echoendoscopes and endobronchial ultrasound scopes. Strategic significance: Maintains Pentax's position among the leading echoendoscope manufacturers and supports competition in scopes.

In 2023 and 2024, Medtronic plc advanced its Beacon endoscopic ultrasound delivery and gastrointestinal device portfolio for tissue acquisition. Strategic significance: Strengthens Medtronic's presence in endoscopic ultrasound accessories and tissue sampling.

In 2024 and 2025, manufacturers and digital health companies advanced artificial-intelligence-assisted endoscopic ultrasound and gastrointestinal endoscopy image analysis. Strategic significance: Improves diagnostic accuracy and addresses the steep learning curve, supporting broader adoption of endoscopic ultrasound.

In 2023 and 2024, therapeutic endoscopic ultrasound procedures, including EUS-guided gallbladder and biliary drainage and gastroenterostomy, expanded with lumen-apposing metal stents. Strategic significance: Broadens the therapeutic scope of endoscopic ultrasound and shifts procedures from surgery to endoscopy.

In 2023 and 2024, SonoScape Medical Corp. and Medi-Globe Group expanded their endoscopic ultrasound scopes and accessories, broadening cost-effective options. Strategic significance: Intensifies competition and broadens access to endoscopic ultrasound in emerging and value-focused markets.

In 2024 and 2025, manufacturers advanced endoscope reprocessing and single-use designs to address infection control concerns in endoscopic ultrasound and related endoscopy. Strategic significance: Addresses regulatory and safety concerns and supports continued adoption of endoscopic technologies.

In 2024 and 2025, the transition to the European Medical Device Regulation continued to shape echoendoscope and accessory compliance and evidence requirements. Strategic significance: Raises clinical evidence standards and favors established manufacturers with resources to comply.

Endoscopic Ultrasound Market Segmentation

Endoscopic Ultrasound Market by Product

• Endoscopic Ultrasound Endoscopes (Echoendoscopes)
• Endoscopic Ultrasound Processors and Imaging Systems
• Needles and Accessories (Fine-Needle Aspiration and Biopsy Devices)

Endoscopic Ultrasound Market by Type

• Radial Endoscopic Ultrasound
• Linear (Curvilinear) Endoscopic Ultrasound
• Endoscopic Ultrasound Miniprobes

Endoscopic Ultrasound Market by Application

• Oncology
• Gastroenterology and Pancreaticobiliary
• Pulmonology (Endobronchial Ultrasound)
• Others

Endoscopic Ultrasound Market by End-User

• Hospitals
• Ambulatory Surgical Centers and Endoscopy Centers
• Others

Endoscopic Ultrasound Market by Geography

• North America Endoscopic Ultrasound Market

• United States Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Canada Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Mexico Endoscopic Ultrasound Market Size in USD million (2023-2034)

• Europe Endoscopic Ultrasound Market

• Germany Endoscopic Ultrasound Market Size in USD million (2023-2034)
• United Kingdom Endoscopic Ultrasound Market Size in USD million (2023-2034)
• France Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Italy Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Spain Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Rest of Europe Endoscopic Ultrasound Market Size in USD million (2023-2034)

• Asia-Pacific Endoscopic Ultrasound Market

• China Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Japan Endoscopic Ultrasound Market Size in USD million (2023-2034)
• India Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Australia Endoscopic Ultrasound Market Size in USD million (2023-2034)
• South Korea Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Endoscopic Ultrasound Market Size in USD million (2023-2034)

• Rest of the World (RoW) Endoscopic Ultrasound Market

• Middle East Endoscopic Ultrasound Market Size in USD million (2023-2034)
• Africa Endoscopic Ultrasound Market Size in USD million (2023-2034)
• South America Endoscopic Ultrasound Market Size in USD million (2023-2034)

Endoscopic Ultrasound Market Recent Industry Trends and Milestones (2023-2026)

Endoscopic Ultrasound Market Startup Funding and Investment Trends

Investment in the endoscopic ultrasound and gastrointestinal endoscopy ecosystem has concentrated on artificial-intelligence-assisted image analysis and advanced diagnostic and therapeutic endoscopy. The following companies illustrate recent funding activity and technology focus.

AI Medical Service is scaling artificial-intelligence models for gastrointestinal endoscopy image analysis to support lesion detection and characterization, while Iterative Health advances AI-based detection for gastrointestinal endoscopy. Additional capital continues to flow toward artificial-intelligence-assisted endoscopy, advanced imaging, and therapeutic endoscopy technologies that complement and enhance endoscopic ultrasound, reflecting investor conviction that AI-driven diagnostic accuracy and expanded therapeutic capability are the next sources of competitive advantage. Collectively, these efforts signal sustained investment in improving diagnostic yield, addressing the specialized skills endoscopic ultrasound requires, and broadening access to advanced endoscopic diagnosis and therapy.

Key Takeaways from the Endoscopic Ultrasound Market Report Study

• Market size analysis for the current endoscopic ultrasound market size (2025), and market forecast for 9 years (2026 to 2034).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
• Key companies dominating the global endoscopic ultrasound market.
• Various opportunities available for competitors in the endoscopic ultrasound market space.
• What are the top-performing segments in 2025? How will these segments perform in 2034?
• Which are the top-performing regions and countries in the current endoscopic ultrasound market scenario?
• Which are the regions and countries where companies should concentrate their opportunities for endoscopic ultrasound market growth in the future?

Target audience who can benefit from this endoscopic ultrasound market report study

• Endoscopic Ultrasound product providers
• Research organizations and consulting companies
• Endoscopic Ultrasound-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in endoscopic ultrasound
• Various end-users who want to know more about the endoscopic ultrasound market and the latest technological developments in the endoscopic ultrasound market.